Author(s)

Gong Qiang ¹

Affiliation(s)

¹ Department of Cardiology, Baoding NO.1 Central Hospital, Baoding, 071000, China

Corresponding Author

Gong Qiang

ABSTRACT

This study aimed to investigate the efficacy of different dosages of rivaroxaban in the treatment of ventricular thrombus. From February 2023 to February 2025, 86 patients from the Department of Cardiology of our hospital were selected and divided into two groups based on the dosage of rivaroxaban: the low-dose group (10 mg/d) and the standard-dose group (20 mg/d). Post-treatment outcomes, including thrombus area, dissolution rate, bleeding events, cardiac function improvement, and changes in D-dimer levels, were observed. Results indicated that after treatment, the standard-dose group showed superior outcomes in thrombus area reduction (P < 0.05), with complete thrombus dissolution and total effective rates of 67.44% and 88.37%, respectively, compared to 44.19% and 74.42% in the low-dose group (P < 0.05). However, the incidence of bleeding events was lower in the low-dose group (P < 0.05). Additionally, after 3 months of treatment, the standard-dose group exhibited a more pronounced decrease in D-dimer levels (P < 0.05). In conclusion, rivaroxaban at a standard dosage of 20 mg/d is more effective than a low dosage of 10 mg/d in reducing thrombus area and D-dimer levels in patients with ventricular thrombus, though it carries an increased risk of mild bleeding. Clinicians should tailor the dosage based on individual patient conditions to optimize therapeutic efficacy and safety. 

KEYWORDS

Rivaroxaban, Different Dosages, Ventricular Thrombus, Clinical Efficacy, Bleeding Risk

CITE THIS PAPER

Gong Qiang, Clinical Efficacy Analysis of Rivaroxaban Dosage in Patients with Ventricular Thrombus. MEDS Public Health and Preventive Medicine (2025) Vol. 5: 78-84. DOI: http://dx.doi.org/10.23977/phpm.2025.050211.

REFERENCES

[1] Lan Yanxian, Lu Haipeng, Lyu Cong, et al. Efficacy and safety of rivaroxaban in anticoagulant therapy for elderly patients with atrial fibrillation[J]. China Modern Doctor, 2025, 63(7):59-62.
[2] Chen Jingyun, Geng Hao. Comparison of rivaroxaban and warfarin in preventing thromboembolic events in patients with non-valvular atrial fibrillation[J]. Modern Medicine and Health Research Electronic Journal, 2025, 9(1):43-45.
[3] Zhang Ji, Lin Changjian, Wang Yaoke, et al. Therapeutic effect of rivaroxaban combined with catheter-directed thrombolysis for acute lower extremity deep vein thrombosis and its influence on coagulation parameters[J]. Chinese Science and Technology Journal Database (Abstract Edition) Medicine and Health, 2024(9):108-111.
[4] Du Juan, Ding Zhaogang, Liu Shaohua. Therapeutic effects of rivaroxaban versus warfarin in patients with non-valvular atrial fibrillation[J]. Chinese Journal of Trauma and Disability Medicine, 2024, 32(17):15-18.
[5] Di Xuan, Cheng Sheng, Wei Hongtao, et al. Systematic evaluation of efficacy and safety of different doses of rivaroxaban in elderly patients with thromboembolic diseases[J]. Evaluation and Analysis of Drug-Use in Hospitals of China, 2021, 21(10):1235-1240.
[6] Zou Shuxia, Song Changshuai, He Fangfang, et al. Clinical analysis of different doses of rivaroxaban for stroke prevention in patients with non-valvular atrial fibrillation[J]. Chinese Science and Technology Journal Database (Citation Edition) Medicine and Health, 2024(10):33-37.
[7] Chen Kangbiao, Ye Yanyan, Wu Ye, et al. Efficacy and safety analysis of different doses of rivaroxaban in treating catheter-related external thrombosis in cancer patients undergoing peripherally inserted central catheterization[J]. Oncology Progress, 2021, 19(24):2537-2539,2558.
[8] Gong Ning. Therapeutic effect of rivaroxaban after percutaneous coronary intervention in patients with atrial fibrillation and its influence on adverse cardiovascular events[J]. Basic Medical Forum, 2025, 29(5):64-66,97.

Sponsors, Associates, and Links

---

• MEDS Clinical Medicine
  
  
• Journal of Neurobiology and Genetics
  
  
• Medical Imaging and Nuclear Medicine
  
  
• Bacterial Genetics and Ecology
  
  
• Transactions on Cancer
  
  
• Journal of Biophysics and Ecology
  
  
• Journal of Animal Science and Veterinary
  
  
• Academic Journal of Biochemistry and Molecular Biology
  
  
• Transactions on Cell and Developmental Biology
  
  
• Rehabilitation Engineering & Assistive Technology
  
  
• Orthopaedics and Sports Medicine
  
  
• Hematology and Stem Cell
  
  
• Journal of Intelligent Informatics and Biomedical Engineering
  
  
• MEDS Basic Medicine
  
  
• MEDS Stomatology
  
  
• MEDS Chinese Medicine
  
  
• Journal of Enzyme Engineering
  
  
• Advances in Industrial Pharmacy and Pharmaceutical Sciences
  
  
• Bacteriology and Microbiology
  
  
• Advances in Physiology and Pathophysiology
  
  
• Journal of Vision and Ophthalmology
  
  
• Frontiers of Obstetrics and Gynecology
  
  
• Digestive Disease and Diabetes
  
  
• Advances in Immunology and Vaccines
  
  
• Nanomedicine and Drug Delivery
  
  
• Cardiology and Vascular System
  
  
• Pediatrics and Child Health
  
  
• Journal of Reproductive Medicine and Contraception
  
  
• Journal of Respiratory and Lung Disease
  
  
• Journal of Bioinformatics and Biomedicine